Keep a close eye on ARRIS Group, Inc. (ARRS). The company

New Post Public Reply Private Reply Replies (0) Message Board
riddock57
Keep a close eye on ARRIS Group, Inc. (ARRS). The company had a strong first quarter achieving record revenue levels and was upgraded from Outperform to Strong Buy and its price target raised from $31.50 to $37.00 per share by brokerage firm Raymond James

On its preliminary and unaudited financial results for the first quarter 2014, ARRS posted revenues of $1,225.0 million, compared to $353.7 million in the same period the prior year, and GAAP net income of $0.28 per diluted share, compared to GAAP net loss of $(0.13) per diluted share in the first quarter 2013

For the second quarter 2014, ARRS expects revenues to be in the range of $1,410 million to $1,450 million, with adjusted net income per diluted share in the range of $0.64 to $0.70 and GAAP net income per diluted share in the range of $0.27 to $0.33

ARRS is a global innovator in IP, video and broadband technology.

More about ARRIS Group, Inc. (ARRS) at www.arrisi.com

**

Crown Equity Holdings Inc. (CRWE) is currently developing its CRWE Network (CRWE-PR.com), a social networking service compatible with both, the mobile and desktop web platform, that is designed to target all the communities in the U.S. and Canada.

The CRWE Network, which business model is based on selling advertising to local businesses, has reached the 523th community website in the U.S., associated with 2086 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida and 10 provinces in Canada

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com or the CRWE Network at www.CRWE-PR.com

**

MagneGas Corporation (MNGA) reported that it has expanded its capability to sell MagneGas(R) metal cutting fuel into California with Placer Power LLC.

Under the terms of the agreement, Placer Power will be selling MNGA's MagneGas fuel into the California market for the metal cutting and fabrication markets. The agreement allows for expansion into other territories based on sales volume and performance requirements.

MNGA's patented Plasma Arc Flow(TM) process gasifies liquid waste, creating a clean burning hydrogen based fuel known as MagneGas(TM) that is essentially interchangeable with natural gas. MNGA's MagneGas can be used for metal working, cooking, heating, powering bi-fuel automobiles and more.

MNGA is a technology Company that counts among its inventions, a patented process that converts liquid waste into hydrogen based fuels. MNGA currently sells MagneGas(R) into the metal working market as a replacement to acetylene. It also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets.

More about MagneGas Corporation (MNGA) at www.MagneGas.com.

**

IGI Laboratories, Inc. (IG) said that it has received tentative approval from the FDA for its abbreviated new drug application (ANDA) for diclofenac sodium topical solution, 1.5%.

Diclofenac sodium topical solution, 1.5% is a nonsteroidal anti-inflammatory drug indicated for the treatment of the pain of osteoarthritis of the knee. Based on recent IMS Health data, the total addressable market for this product is approximately $29 million

This tentative approval marks the second approval of an IG ANDA by the FDA and the company believes is a further validation of its pipeline. The launch of this product will be conditioned on resolving the patent issues that surround the product.

IG is a generic topical pharmaceutical company. It develops and manufactures topical formulations for the pharmaceutical, OTC, and cosmetic markets.

More about IGI Laboratories, Inc. (IG) at www.igilabs.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

Arris Group Inc. (ARRS) Stock Research Links

ARRS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles